About 400,000 people in Europe live with Pulmonary Fibrosis and some 100,000 patients die each year from the disease. The most common type of PF is IPF (Idiopathic Pulmonary Fibrosis), accounting for 200,000 patients in Europe. EU-IPFF, the European Patient organization presently runs the “Breathing Life” campaign to raise awareness of the disease and encourages spread of the campaign. Oxcia is happy to share.
Oxcia AB (publ) (“Oxcia”) har idag offentliggjort årsredovisningen för 2022.
Oxcia AB (publ) (“Oxcia”) has today published the annual report for 2022.
Aktieägarna i Oxcia AB, org.nr 556932–4717, (”Bolaget”) kallas till årsstämma tisdagen den 13 juni 2023 klockan 17:00 i Life city, Solnavägen 3, Solna. Rätt att deltaga samt anmälan Rätt att delta i stämman har den som är registrerad som… Continue reading Kallelse till årsstämma i Oxcia AB (publ) den 13 juni 2023
